Megakaryon Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
12
- Latest Deal Type
-
M&A
Megakaryon General Information
Description
Developer of a regenerative medicine platform designed to produce engineered platelets and extracellular vesicles from iPSC-derived megakaryocyte cell banks. The company offers standardized, scalable cell manufacturing processes based on induced pluripotent stem cells, enabling researchers and clinicians in transfusion medicine and cell therapy to access consistent, lab-grown blood components for therapeutic and research applications.
Contact Information
Website
www.megakaryon.com(Operating Subsidiary)
Corporate Office
- Kyoto Research Park Building Number 2
- 134 Chudojiminami-machi, Shimogyo-ku
- Kyoto, 600-8813
- Japan
Corporate Office
- Kyoto Research Park Building Number 2
- 134 Chudojiminami-machi, Shimogyo-ku
- Kyoto, 600-8813
- Japan
Megakaryon Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 21-Dec-2023 | Completed | Pre-Clinical Trials | |||
| 6. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 5. Later Stage VC (Series D) | 17-Feb-2020 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 01-Jun-2018 | Completed | Pre-Clinical Trials | |||
| 3. Later Stage VC (Series C) | 04-Jan-2018 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC (Series B) | 23-Mar-2015 | $20.8M | $37.1M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 26-Aug-2013 | $16.4M | $16.4M | Completed | Startup |
Megakaryon Comparisons
Industry
Financing
Details
Megakaryon Competitors (4)
One of Megakaryon’s 4 competitors is HemostOD, a Venture Capital-Backed company based in Saint-Sulpice, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| HemostOD | Venture Capital-Backed | Saint-Sulpice, Switzerland | ||||
| AdipoSeeds | Venture Capital-Backed | Tokyo, Japan | ||||
| DewCell | Venture Capital-Backed | Seongnam, South Korea | ||||
| HemaCell | Venture Capital-Backed | Suzhou, China |
Megakaryon Patents
Megakaryon Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026159689-A | Composition | Pending | 19-Mar-2025 | ||
| WO-2025178117-A1 | Composition for use in suppressing differentiation into osteoclasts | Pending | 21-Feb-2024 | ||
| WO-2025173790-A1 | Bone-forming composition | Pending | 14-Feb-2024 | ||
| WO-2023153401-A1 | Agitation device for producing platelet, and control method for said agitation device | Inactive | 10-Feb-2022 | ||
| AU-2022292342-A1 | Method for producing multinucleated megakaryocyte with enhanced platelet production capability, method for producing platelets, method for producing platelet preparation, and method for producing blood preparation | Pending | 18-Jun-2021 | C12N5/0644 |
Megakaryon Signals
Megakaryon Former Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CMIC Holdings | Holding Company | Minority | ||
| DBJ Capital | Corporate Venture Capital | Minority | ||
| Innovation Network Corporation of Japan | Growth/Expansion | Minority | ||
| J-Startup | Accelerator/Incubator | |||
| Japan Asia Investment | PE/Buyout | Minority |
Megakaryon FAQs
-
When was Megakaryon founded?
Megakaryon was founded in 2011.
-
Where is Megakaryon headquartered?
Megakaryon is headquartered in Kyoto, Japan.
-
What is the size of Megakaryon?
Megakaryon has 12 total employees.
-
What industry is Megakaryon in?
Megakaryon’s primary industry is Biotechnology.
-
Is Megakaryon a private or public company?
Megakaryon is a Private company.
-
What is Megakaryon’s current revenue?
The current revenue for Megakaryon is .
-
How much funding has Megakaryon raised over time?
Megakaryon has raised $95.5M.
-
Who are Megakaryon’s investors?
CMIC Holdings, DBJ Capital, Innovation Network Corporation of Japan, J-Startup, and Japan Asia Investment are 5 of 19 investors who have invested in Megakaryon.
-
Who are Megakaryon’s competitors?
HemostOD, AdipoSeeds, DewCell, and HemaCell are competitors of Megakaryon.
-
When was Megakaryon acquired?
Megakaryon was acquired on 21-Dec-2023.
-
Who acquired Megakaryon?
Megakaryon was acquired by Sysmex (Diagnostic Equipment).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process